Generate a tailored SOP for Dr. Yibin Kang. Improve your application with a focused, well-structured draft.
Yibin Kang is a founding member of the Ludwig Institute for Cancer Research at Princeton Branch and serves as the Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University. He is also the associate director at the Rutgers Cancer Institute of New Jersey. Kang obtained his bachelor’s degree from Fudan University in Shanghai in 1995 and completed his graduate studies at Duke University in 2000, followed by postdoctoral training under Dr. Joan Massagué at the Memorial Sloan-Kettering Cancer Center. He joined the Princeton University faculty as an assistant professor of molecular biology in 2004 and was promoted to associate professor with tenure in 2010, receiving an endowed chair as a full professor in 2012. Kang has served in leadership roles, including president of the Metastasis Research Society from 2016 to 2018 and chair of the American Association for Cancer Research (AACR) Tumor Microenvironment Working Group from 2018 to 2019. His research focuses on the molecular mechanisms of breast cancer metastasis, with significant contributions made towards understanding tumor-stromal interactions and developing novel therapeutic agents. He has published over 180 original articles in prestigious journals and has received numerous awards, including the American Cancer Society Research Scholar Award in 2005 and the AACR Outstanding Investigator Award in 2014. He was elected a fellow of the American Association for the Advancement of Science (AAAS) in recognition of his contributions to the field.
Ludwig Institute for Cancer Research • Princeton, NJ
Founding member at the Ludwig Institute for Cancer Research, focusing on cancer biology.
Princeton University • Princeton, NJ
Serving as a professor in Molecular Biology, leading innovative cancer research.
GRE scores are not accepted. Ph.D. is the primary degree; students are not required to hold an M.S.E. prior to admission.